DEXCOM INC. DL-,001/ US2521311074 /
5/20/2024 7:55:31 PM | Chg. -0.20 | Volume | Bid8:00:06 PM | Ask8:00:06 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
120.58EUR | -0.17% | 0 Turnover: 0.00 |
-Bid Size: - | -Ask Size: - | 47.87 bill.EUR | - | - |
GlobeNewswire
4/8
Precision Neuroscience Names Verily Co-Founder Brian Otis as Chief Technology Officer
GlobeNewswire
1/31
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.